Skip to Content

LET 2.5 (Letrozole 2.5 mg)

Pill imprint LET 2.5 has been identified as Letrozole 2.5 mg.

Letrozole is used in the treatment of female infertility; breast cancer, metastatic; breast cancer; breast cancer, adjuvant and belongs to the drug classes aromatase inhibitors, hormones/antineoplastics. There is positive evidence of human fetal risk during pregnancy. Letrozole 2.5 mg is not a controlled substance under the Controlled Substance Act (CSA).

Letrozole
Imprint:
LET 2.5
Strength:
2.5 mg
Color:
Yellow
Shape:
Round
Availability:
Prescription only
Drug Class:
Aromatase inhibitors
Hormones/antineoplastics
Pregnancy Category:
D - Positive evidence of risk
CSA Schedule:
Not a controlled drug
Manufacturer:
Dr. Reddy's Laboratories Limited
National Drug Code (NDC):
55111-0646
Inactive Ingredients:
silicon dioxide colloidal
croscarmellose sodium
hypromelloses
lactose monohydrate
magnesium stearate
polyethylene glycol
povidone
magnesium silicate
titanium dioxide
ferric oxide yellow

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide